Bex A - Search Results

1

Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.

Kuusk T, Klatte T, Zondervan P, Lagerveld B, Graafland N, Hendricksen K, Capitanio U, Minervini A, Stewart GD, Ljungberg B, Horenblas S, Bex A. Kuusk T, et al. Among authors: bex a. World J Urol. 2021 Sep;39(9):3377-3383. doi: 10.1007/s00345-021-03633-5. Epub 2021 Feb 25. World J Urol. 2021. PMID: 33634323

2

Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.

Bex A, Vooijs M, Horenblas S, Berns A. Bex A, et al. J Urol. 2002 Dec;168(6):2641-4. doi: 10.1016/S0022-5347(05)64235-8. J Urol. 2002. PMID: 12442001

3

Unusual complication after immediate postoperative intravesical mitomycin C instillation.

Nieuwenhuijzen JA, Bex A, Horenblas S. Nieuwenhuijzen JA, et al. Among authors: bex a. Eur Urol. 2003 Jun;43(6):711-2. doi: 10.1016/s0302-2838(03)00151-9. Eur Urol. 2003. PMID: 12767376

4

The timing of immunotherapy and nephrectomy in multimodality treatment of metastatic renal cell carcinoma.

Bex A, Horenblas S, de Gast GC. Bex A, et al. Technol Cancer Res Treat. 2003 Jun;2(3):205-10. doi: 10.1177/153303460300200304. Technol Cancer Res Treat. 2003. PMID: 12779351 Free article. Review.

5

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor.

Bex A, Mallo H, Kerst M, Haanen J, Horenblas S, de Gast GC. Bex A, et al. Cancer Immunol Immunother. 2005 Jul;54(7):713-9. doi: 10.1007/s00262-004-0630-9. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627213 Free PMC article. Clinical Trial.

6

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.

Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S. Bex A, et al. Urology. 2005 Feb;65(2):295-9. doi: 10.1016/j.urology.2004.09.049. Urology. 2005. PMID: 15708041

7

Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience.

Kroon BK, Horenblas S, Meinhardt W, van der Poel HG, Bex A, van Tinteren H, Valdés Olmos RA, Nieweg OE. Kroon BK, et al. Among authors: bex a. Eur Urol. 2005 May;47(5):601-6; discussion 606. doi: 10.1016/j.eururo.2004.11.018. Epub 2005 Jan 22. Eur Urol. 2005. PMID: 15826750

8

Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.

Verra N, de Jong D, Bex A, Batchelor D, Dellemijn T, Sein J, Nooijen W, Meinhardt W, Horenblas S, de Gast G, Vyth-Dreese F. Verra N, et al. Among authors: bex a. Eur Urol. 2005 Sep;48(3):527-33. doi: 10.1016/j.eururo.2005.03.031. Epub 2005 Apr 11. Eur Urol. 2005. PMID: 16115526 Clinical Trial.

9

Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study.

Bex A, Kerst M, Mallo H, Meinhardt W, Horenblas S, de Gast GC. Bex A, et al. Eur Urol. 2006 Jan;49(1):76-81. doi: 10.1016/j.eururo.2005.09.011. Epub 2005 Nov 2. Eur Urol. 2006. PMID: 16310929 Clinical Trial.

10

Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations.

Meinhardt W, Valdés Olmos RA, van der Poel HG, Bex A, Horenblas S. Meinhardt W, et al. Among authors: bex a. BJU Int. 2008 Sep;102(6):714-7. doi: 10.1111/j.1464-410X.2008.07674.x. Epub 2008 Apr 10. BJU Int. 2008. PMID: 18410427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters